BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

October 20–21, 2026
Manchester, New Hampshire
Hosted by the ARMI BioFab Startup Lab in partnership with the NextGen Manchester Resiliency Council
Commercializing breakthrough technologies takes more than great science—it requires investment, manufacturing expertise, strategic partnerships, and the right ecosystem.
The 2026 BioFab Investment Summit, hosted by ARMI’s BioFab Startup Lab, brings together entrepreneurs, investors, commercialization experts, manufacturers, economic development leaders, and industry partners to accelerate the commercialization of regenerative medicine and biotechnology innovations.
As the nation’s Manufacturing Innovation Institute for regenerative medicine, ARMI | BioFabUSA helps bridge the gap between scientific discovery and scalable manufacturing. The BioFab Investment Summit extends that mission by connecting founders with the expertise, partnerships, and capital needed to move breakthrough technologies toward commercial success.
Through expert-led discussions, founder success stories, interactive workshops, and strategic networking, attendees will gain practical insights while building relationships that accelerate commercialization and company growth.
BioFab Pitch Competition
On Day One of the Summit, 10 emerging companies will be selected to present their technologies before a panel of investors, commercialization experts, and industry leaders.
Selected companies will:
Over two days, attendees will explore the technologies, partnerships, and commercialization strategies shaping the future of regenerative medicine.
Highlights include:
One of this year’s featured educational experiences is the Bioindustrial Stack Workshop. Drawing on ARMI’s expertise in advanced biomanufacturing and commercialization, this workshop explores the interconnected capabilities required to successfully scale advanced therapies, including:
Participants will engage in facilitated discussions with ARMI subject matter experts and industry leaders while developing a practical understanding of what it takes to successfully scale breakthrough technologies.
The BioFab Investment Summit is designed for:
Whether you’re building a startup, investing in transformative technologies, or supporting commercialization across the bioindustrial ecosystem, the 2026 Investment Summit offers meaningful connections, practical insights, and access to ARMI’s national network of innovators, manufacturers, investors, and strategic partners.
Attendee registration will open in early August.
Organizations interested in supporting the BioFab Investment Summit through sponsorship will have the opportunity to showcase their commitment to advancing biotechnology innovation and commercialization.
Sponsorship packages will be announced soon.